Johnson & Johnson Enterprise Innovation Inc.

7 clinical trials · Sponsor

Record	Firm	Date
A Study of JNJ-1761981 in Participants With Solid Tumors (NCT07525141)	Johnson & Johnson Enterprise Innovation Inc.	2026-05-18
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07219212)	Johnson & Johnson Enterprise Innovation Inc.	2026-01-26
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) (NCT06667908)	Johnson & Johnson Enterprise Innovation Inc.	2024-12-06
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors (NCT06311578)	Johnson & Johnson Enterprise Innovation Inc.	2024-04-10
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer (NCT06116786)	Johnson & Johnson Enterprise Innovation Inc.	2023-11-27
Confocal Laser Endomicroscopy Nodule Localization by Robotic Bronchoscopy (NCT05231278)	Johnson & Johnson Enterprise Innovation Inc.	2022-01-20
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC (NCT04892173)	Johnson & Johnson Enterprise Innovation Inc.	2021-12-10

Every clearance here is in the API, with alerts when new ones post.